Resources for the practice of pediatric neuro-oncology in Mexico: a cross-sectional evaluation.

Autor: Arce-Cabrera D; Pediatric Oncology Department, Sinaloa Pediatric Hospital, Culiacan, Sinaloa, Mexico., Escamilla-Asiain G; Pediatric Oncology Department, Teletón Children's Hospital of Oncology, Querétaro, Querétaro, Mexico., Nájera-Castillo MF; Pediatric Oncology Department Hospital for Children of Toluca. Maternal and Child Institute of the State of Mexico, Toluca, Estado de Mexico, Mexico., Navarro-Martín Del Campo RM; Pediatric Oncology Department, Civil Hospital of Guadalajara Dr. Juan I. Menchaca, Guadalajara, Jalisco, Mexico., Ortiz-Azpilcueta M; Pediatric Oncology Department, Pediatric Hospital of the National Medical Center 21st century Mexican Social Security Institute (IMSS), Mexico City, Mexico., Pantoja-Guillén FJ; Pediatric Oncology Department, Agustín O'Horán General Hospital, Merida, Yucatan, Mexico., Arreguín González FE; Pediatric Oncology Department, National Medical Center November 20 ISSSTE, Mexico City, Mexico., Zapata-Sosa I; Pediatric Oncology Department, Zacatecas General Hospital, Zacatecas, Zacatecas, Mexico., Lugo-Juárez JZ; Pediatric Oncology Department, Teletón Children's Hospital of Oncology, Querétaro, Querétaro, Mexico., Santillán Cortéz D; Pediatric Oncology Department, National Medical Center November 20 ISSSTE, Mexico City, Mexico., Morales-La Madrid A; Barcelona Pediatric Oncology Center, Saint Joan de Déu Hospital, Barcelona, Spain., Moreira DC; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States., Benito-Reséndiz AE; Pediatric Oncology Department, National Medical Center November 20 ISSSTE, Mexico City, Mexico.

Publikováno v: Frontiers in oncology [Front Oncol] 2024 Jun 21; Vol. 14, pp. 1330705. Date of Electronic Publication: 2024 Jun 21 (Print Publication: 2024).

Impact of treatment and clinical characteristics on the survival of children with medulloblastoma in Mexico.

Autor: Salceda-Rivera V; Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Department of Pediatrics, Divisions of Pediatric Hematology-Oncology, Guadalajara, Jalisco, Mexico., Tejocote-Romero I; IMIEM, Instituto Materno Infantil del Estado de Mexico, Secretaria de Salud, Toluca, Estado de Mexico, Mexico.; Department of Pediatric Oncology, ISSEMYM, Instituto de Seguridad Social del Estado de México y Municipios, Toluca, Estado de Mexico, Mexico., Osorio DS; ICON PLC, Clinical Research Organization, Dublin, Ireland., Bellido-Magaña R; Hospital General Regional de Leon, Leon, Guanajuato, Mexico., López-Facundo A; Department of Pediatric Oncology, ISSEMYM, Instituto de Seguridad Social del Estado de México y Municipios, Toluca, Estado de Mexico, Mexico., Anaya-Aguirre SE; Instituto Mexicano del Seguro Social, Centro Médico Nacional La Raza, Mexico City, Mexico., Ortiz-Morales D; Department of Pediatric Oncology, Hospital General de México 'Dr. Eduardo Liceaga', Mexico City, Mexico.; Department of Pediatric Oncology, Hospital Militar de Especialidades de la Mujer y Neonatología, Mexico City, Mexico., Rivera-Luna R; Department of Pediatric Oncology, Instituto Nacional de Pediatria, Mexico City, Mexico., Reyes-Gutiérrez E; Hospital de Especialidades del Niño y de la Mujer, Secretaria de Salud, Queretaro, Mexico., Rivera-Gómez R; Hospital General de Tijuana, Universidad Autonoma de Baja California, Tijuana, Baja California, Mexico., Velasco-Hidalgo L; Department of Pediatric Oncology, Instituto Nacional de Pediatria, Mexico City, Mexico., Cortés-Alva D; Hospital del Niño DIF Hidalgo, Sistema Nacional para el Desarrollo Integral de la Familia, Hidalgo, Mexico., Lagarda-Arrechea S; Department of Pediatric Oncology, Instituto Estatal de Cancerologia, Colima, Mexico., Arreguín-González FE; Centro Médico Nacional '20 de Noviembre' del Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Mexico City, Mexico., Benito-Reséndiz AE; Centro Médico Nacional '20 de Noviembre' del Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Mexico City, Mexico., Chávez-Gallegos S; Department of Pediatric Oncology, Hospital Infantil 'Eva Samano de López Mateos', Morelia, Michoacan, Mexico., Pérez-Rivera E; Department of Pediatric Oncology, Hospital Infantil 'Eva Samano de López Mateos', Morelia, Michoacan, Mexico., Gaytán-Fernández GJ; Hospital General Regional de Leon, Leon, Guanajuato, Mexico.; Department of Pediatric Oncology, Hospital Regional de Alta Especialidad del Bajío, Leon, Guanajuato, Mexico., León-Espitia JA; Hospital General Regional de Leon, Leon, Guanajuato, Mexico., Domínguez-Sánchez J; Department of Pediatric Oncology, Centenario Hospital Miguel Hidalgo, Aguascalientes, Mexico., Leal-Cavazos C; Hospital Universitario 'Dr. José Eleuterio González', Universidad Autónoma de Nuevo Leon, Nuevo Leon, Mexico., Simón-González C; Department of Pediatric Oncology, Hospital Regional de Alta Especialidad del Niño ' Dr. Rodolfo Nieto Padrón', Tabasco, Mexico., Larios-Farak TC; Department of Pediatric Oncology, Hospital Infantil del Estado de Sonora, Hermosillo, Sonora, Mexico., Macías-García NA; Department of Pediatric Oncology, Hospital del Niño 'Dr. Federico Gómez Santos', Saltillo, Coahuila, Mexico., García-Espinosa AC; Department of Pediatric Oncology, Hospital Infantil de Especialidades de Chihuahua, Chihuahua, Chihuahua, Mexico., Guerrero-Maymes F; Department of Pediatric Oncology, Hospital General de Occidente, Zapopan, Jalisco, Mexico., Casillas-Toral P; Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Department of Pediatrics, Divisions of Pediatric Hematology-Oncology, Guadalajara, Jalisco, Mexico., González-Ramella O; Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Department of Pediatrics, Divisions of Pediatric Hematology-Oncology, Guadalajara, Jalisco, Mexico.

Publikováno v: Frontiers in oncology [Front Oncol] 2024 May 02; Vol. 14, pp. 1376574. Date of Electronic Publication: 2024 May 02 (Print Publication: 2024).